相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
Robert M. Cox et al.
NATURE MICROBIOLOGY (2021)
New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19
Muneerah M. Aleissa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V'kovski et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Asymptomatic cases in a family cluster with SARS-CoV-2 infection
Xingfei Pan et al.
LANCET INFECTIOUS DISEASES (2020)
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
Lirong Zou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Camilla Rothe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Pathogenesis of COVID-19 from a cell biology perspective
Robert J. Mason
EUROPEAN RESPIRATORY JOURNAL (2020)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
Ruiyun Li et al.
SCIENCE (2020)
Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis
Peter J. Dickinson et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
M. M. Arons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects
Rita Humeniuk et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
Brandi N. Williamson et al.
NATURE (2020)
Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment
Victoria C. Yan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
Andrea J. Pruijssers et al.
CELL REPORTS (2020)
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison et al.
TRENDS IN IMMUNOLOGY (2020)
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
Xuping Xie et al.
NATURE COMMUNICATIONS (2020)
Virology, transmission, and pathogenesis of SARS-CoV-2
Muge Cevik et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
FDA Approval of Remdesivir - A Step in the Right Direction
Daniel Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
y COVID-19 transmission-up in the air
[Anonymous]
LANCET RESPIRATORY MEDICINE (2020)
Metabolic Efficacy of Phosphate Prodrugs and the Remdesivir Paradigm
Andrew J. Wiemer
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Reproductive number of coronavirus: A systematic review and meta-analysis based on global level evidence
Md. Arif Billah et al.
PLOS ONE (2020)
SARS-CoV-2 viral load is associated with increased disease severity and mortality
Jesse Fajnzylber et al.
NATURE COMMUNICATIONS (2020)
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Steven Sanche et al.
EMERGING INFECTIOUS DISEASES (2020)
Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis
Niels C. Pedersen et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2019)
Pharmacokinetics of Tenofovir Alafenamide, Tenofovir, and Emtricitabine Following Administration of Coformulated Emtricitabine/Tenofovir Alafenamide in Healthy Japanese Subjects
Hiroyuki Yamada et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
The ProTide Prodrug Technology: From the Concept to the Clinic
Youcef Mehellou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies
B. G. Murphy et al.
VETERINARY MICROBIOLOGY (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses
Dustin Siegel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Michael K. Lo et al.
SCIENTIFIC REPORTS (2017)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
Dynamic Regulation of the Adenosine Kinase Gene during Early Postnatal Brain Development and Maturation
Katharina Kiese et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir
Brian J. Kirby et al.
CLINICAL PHARMACOKINETICS (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Cobicistat Boosts the Intestinal Absorption of Transport Substrates, Including HIV Protease Inhibitors and GS-7340, In Vitro
Eve-Irene Lepist et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides
Aesop Cho et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Discovery of a β-D-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
Michael J. Sofia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Adenosine kinase and ribokinase - the RK family of proteins
J. Park et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Empirical regioselectivity models for human cytochromes p450 3A4, 2D6, and 2C9
Robert P. Sheridan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma
B Li et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue
WA Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Aromatic hydroxylation by cytochrome P450: Model calculations of mechanism and substituent effects
CM Bathelt et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
分享论文
